Frontiers in Cardiovascular Medicine

JANUARY 20, 2025

ObjectiveThe aim of this retrospective study was to evaluate the usefulness of non-contrast cardiac magnetic resonance imaging, including cine imaging, T1 and T2 mapping, and texture analysis for T1 mapping, for identifying etiologies of heart failure (HF).MethodsForty-seven MethodsForty-seven patients with HF were examined using a 1.5T

Heart Failure 52

Heart Failure Cardiomyopathy Tachycardia Hypertension 52

Frontiers in Cardiovascular Medicine

JULY 24, 2024

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a severe and complex condition that evolves from unresolved pulmonary embolism, leading to fibrotic obstruction of pulmonary arteries, pulmonary hypertension, and potential right heart failure.

Pulmonary 98

Pulmonary Hypertension Angioplasty Pharmacology 98

Medical Xpress - Cardiology

JULY 8, 2024

Pulmonary hypertension is a very serious disease that leads to heart failure and death in many patients.

Pulmonary 89

Pulmonary Hypertension Physiology Heart Failure 89

DAIC

FEBRUARY 14, 2025

The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic (Echo) markers of diastolic dysfunction, an important component in the development of heart failure, in hypertensive patients. Advanced Heart Failure Cardiologist, Duke Health on Feb.

Blood Pressure 52

Blood Pressure Heart Failure Hypertension Technology 52

HCPLive

MARCH 26, 2025

Other risk factors in the population included PZA or ETB use, hypertension, heart failure, and chronic kidney disease.

Kidney Disease 112

Kidney Disease Heart Failure Risk Factors Hypertension 112

DAIC

FEBRUARY 12, 2024

Barostim is the world’s first FDA-approved neuromodulation heart failure device, which works by stimulating baroreceptors — natural sensors located in the wall of the carotid artery, according to CVRx. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure.

Heart Failure 104

Heart Failure Hospital Quality of Life Heart Attack 104

DAIC

MAY 8, 2024

Bioelectronic medicine scientists at The Feinstein Institutes for Medical Research used noninvasive, splenic focused ultrasound stimulation (sFUS) and found they can reduce inflammation and improve symptoms of pulmonary arterial hypertension (PAH).

Ultrasound 115

Ultrasound Pulmonary Research Hypertension 115

Medical Xpress - Cardiology

MAY 2, 2024

This difference becomes clear in pulmonary hypertension, in which only the lungs' blood vessels stiffen progressively, leading to chronic lung disease, heart failure and death. Blood vessels in the lungs aren't like the others in the body.

Pulmonary 75

Pulmonary Hypertension Heart Failure 75

DAIC

MAY 16, 2024

Getty Images milla1cf Thu, 05/16/2024 - 15:37 May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced adverse effects of economic and social conditions that influence individual and group differences in health status, known as social determinants of health. Over a period of 9.5

Hypertension 105

Hypertension Blood Pressure Health Disparities Heart Attack 105

Heart BMJ

SEPTEMBER 16, 2024

Background Cancer survivors are at increased risk of heart failure (HF). to 1.25), p=0.003) and hypertension (OR 0.95, 95% CI (0.92 Objectives This systematic review sought to investigate the relationship between cardiotoxic cancer therapies and HF during survivorship. to 0.99), p=0.047), age (OR 1.14, 95% CI (1.04

Cancer 98

Cancer Heart Failure Risk Factors Hypertension 98

Frontiers in Cardiovascular Medicine

MARCH 18, 2025

Finally, we also emphasize the preclinical/clinical translational significance of neutrophil-targeted strategies.

Cardiovascular Disease 52

Cardiovascular Disease Atrial Fibrillation Atherosclerosis Ischemia 52

Frontiers in Cardiovascular Medicine

MARCH 30, 2025

Infection (75.47%, 160/212) and heart failure (51.42%, 109/212) were common comorbidities. The independent risk factors for mortality included left ventricular ejection fraction (LVEF), pulmonary hypertension, and low-density lipoprotein (LDL) levels (P<0.05).

Risk Factors 52

Risk Factors Pediatrics Cardiomyopathy Pulmonary 52

Frontiers in Cardiovascular Medicine

DECEMBER 3, 2024

In most studies, TCM has been associated with significant improvements in alternative endpoints such as hypertension, coronary heart disease, stroke and heart failure. A total of 19 trials reported on primary outcomes such as cardiovascular events and death events.

Cardiovascular Disease 52

Cardiovascular Disease Heart Failure Heart Disease Hypertension 52

MIBHS

FEBRUARY 15, 2025

High blood pressure, also known as hypertension, is a common condition that affects millions of people worldwide. Often referred to as the silent killer, hypertension can quietly damage your heart and other vital organs over time. Hypertension is diagnosed when blood pressure consistently reads 130/80 mm Hg or higher.

Blood Pressure 52

Blood Pressure Hypertension Chest Pain ACE Inhibitor 52

DAIC

JANUARY 19, 2024

The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation (“AVIM”) therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications. Orchestra BioMed and Medtronic, Inc. Kowal, M.D., and Europe.

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105

American Heart News - Stroke News

SEPTEMBER 11, 2023

American Heart Association Hypertension Scientific Sessions – Abstract 452.

Blood Pressure 143

Blood Pressure Heart Failure Heart Disease Hypertension 143

American College of Cardiology

FEBRUARY 5, 2024

Hypertension represents a major modifiable risk factor for coronary artery disease (CAD), heart failure (HF), stroke, chronic kidney disease (CKD), and dementia.

Hypertension 75

Hypertension Coronary Artery Disease Kidney Disease Dementia 75

Science Daily - Heart Disease

AUGUST 30, 2024

ABYSS suggests that long-term beta-blocker therapy is recommended after an MI, even in the absence of heart failure, arrhythmia or uncontrolled hypertension.

Heart Attack 131

Heart Attack Heart attacks Quality of Life Myocardial Infarction 131

Cardiovascular Diabetology

NOVEMBER 14, 2024

Heart failure combined with hypertension is a major contributor for elderly patients (≥ 65 years) to in-hospital mortality. However, there are very few models to predict in-hospital mortality in such elderly p.

Heart Failure 52

Heart Failure Hypertension Hospital Research 52

Cardiovascular Diabetology

AUGUST 11, 2024

We evaluated the prevalence of “heart stress” (HS) based on NT-proBNP cut-points proposed by the 2023 Consensus of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in asymptomati.

Blood Pressure 111

Blood Pressure Heart Failure Hypertension Diabetes 111

Open Heart

FEBRUARY 4, 2025

Background Left ventricular diastolic function as assessed by tissue Doppler echocardiography predicts cardiovascular event rates at 4 years of follow-up in patients with hypertension. Results Among 506 hypertensive patients (median age 64, interquartile range (58, 69), 87% male), there were 200 (40%) deaths over a 20-year follow-up period.

Outcomes 52

Outcomes Hypertension Heart Failure Cardiovascular Disease 52

Open Heart

DECEMBER 7, 2023

Objectives Prognostic impact of lung ultrasound-derived B-lines (LUS-BL) in heart failure with mildly reduced left ventricular ejection fraction (HFmrEF) patients remains elusive. Older age, hypertension (HR=2.06, 95% CI 1.31 We evaluated the correlation between LUS-BL and prognosis in HFmrEF patients.

Ultrasound 98

Ultrasound Heart Failure Risk Factors Bicuspid/Mitral 98

American College of Cardiology

FEBRUARY 11, 2025

What is the safety and utility of invasive implanted hemodynamic monitoring (IHM) using the CardioMEMS™ HF System in pediatric patients with heart failure (HF) and pulmonary hypertension (PH)?

Pediatrics 46

Pediatrics Heart Failure Pulmonary Hypertension 46

DAIC

FEBRUARY 10, 2025

6, 2025 Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, recently announcedpublication of a peer-reviewed study evaluating its novel algorithm for the detection of pulmonary hypertension (PH). tim.hodson Mon, 02/10/2025 - 12:43 Feb.

Research 64

Research Innovation Pulmonary Hypertension 64

Cardiovascular Diabetology

OCTOBER 22, 2024

Hypertension (HTN) and diabetes mellitus (DM) are two common comorbidities of heart failure with reduced ejection fraction (HFrEF), each of which can cause right ventricular (RV) dysfunction. The aim of this s.

Heart Failure 52

Heart Failure Hypertension Diabetes Research 52

Frontiers in Cardiovascular Medicine

JULY 17, 2024

Recently, indisputable evidence has shown that the TyG index is strongly associated with cardiovascular disease [CVD, including atherosclerosis, heart failure (HF), and hypertension] prognosis and mortality.

Heart Failure 64

Heart Failure Atherosclerosis Biomarkers Obesity 64

Medical Xpress - Cardiology

MARCH 4, 2025

In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary hypertension, a disease that results in abnormally high blood pressure in the lung arteries and can lead to heart failure. But pulmonary hypertension still persists.

Pulmonary 54

Pulmonary Hypertension Blood Pressure Heart Failure 54

Open Heart

MAY 23, 2024

Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes. It is not known whether heart failure increases the risk of pre-eclampsia. This study examines whether pregestational heart failure increases the risk of pre-eclampsia.

Heart Disease 98

Heart Disease Heart Failure Risk Factors Obesity 98

European Journal of Heart Failure

NOVEMBER 19, 2024

Hypertensive disorders of pregnancy as a risk factor for heart failure. Hypertensive disorders of pregnancy (HDP) occur in almost 10% of gestations and preeclampsia, a more severe form, in 34%.

Risk Factors 40

Risk Factors Heart Failure Hypertension Preserved Ejection Fraction 40

Frontiers in Cardiovascular Medicine

FEBRUARY 27, 2024

However, this comes at a cost with more women developing diabetes, hypertension and coronary artery disease as they age. These traditional cardiovascular risk factors not only increase their lifetime risk of heart failure but also their overall risk of cancer. Women continue to enjoy a greater life expectancy than men.

Heart Failure 59

Heart Failure Cancer Coronary Artery Disease Article 59

DAIC

JUNE 4, 2024

American College of Cardiology (ACC) and American Heart Association (AHA) Issue New Hypertrophic Cardiomyopathy (HCM) Management Guidelines 2. New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged 3.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Peripheral Arterial Disease Heart Failure Atrial Fibrillation 105

European Journal of Heart Failure

FEBRUARY 5, 2025

Methods and results TRED-HF was a randomized trial investigating heart failure therapy withdrawal in patients with recovered DCM over 6months. The primary outcome was relapse defined as 10% reduction in left ventricular ejection fraction to 400ng/L, or clinical features of heart failure.

Heart Failure 67

Heart Failure Cardiomyopathy Atrial Fibrillation Arrhythmia 67

Frontiers in Cardiovascular Medicine

DECEMBER 17, 2023

These conditions have an increasing share in the health burden worldwide due to worsening endemic of hypertension, obesity, and diabetes. However, the same set of genes were significantly induced in the Trp53inp2-cKO hearts under both mechanical and metabolic stresses.

Heart Failure 64

Heart Failure Diet Obesity Diabetes 64

Journal of Clinical Investigation - Cardiology

DECEMBER 15, 2023

Heart failure with preserved ejection fraction (HFpEF) is a widespread syndrome with limited therapeutic options and poorly understood immune pathophysiology.

Preserved Ejection Fraction 75

Preserved Ejection Fraction Heart Failure Obesity Ablation 75

Heart BMJ

DECEMBER 23, 2024

Current guideline indications for intervention in asymptomatic patient are centred on left ventricular dimensions and ejection fraction and may include consideration in atrial fibrillation, pulmonary hypertension and those with left atrial dilatation.

Bicuspid/Mitral 59

Bicuspid/Mitral Atrial Fibrillation Heart Failure Pulmonary 59

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

BackgroundAnemia is a common complication in patients with heart failure and is associated with left ventricular systolic dysfunction.

Preserved Ejection Fraction 59

Preserved Ejection Fraction Heart Failure Tricuspid Atrial Fibrillation 59

Hypertension Journal

FEBRUARY 22, 2024

Hypertension, Ahead of Print. In modeling, the risk for any cardiovascular disease event among women with a history of hypertensive disorders of pregnancy was generally 10% to 20% higher, with main models estimating hazard ratios to 1.20 (95% CI, 0.99–1.47) years for women with type 1 and 29.8 years for women with type 2 diabetes.

Cardiovascular Disease 74

Cardiovascular Disease Hypertension Diabetes Myocardial Infarction 74